Chugai

Roche Holding AG decided against bidding for the almost 40 percent of drugmaker Chugai Pharmaceutical Co. that it doesn't already own and is instead focused on its $8.3 billion acquisition of InterMune Inc., according to a person familiar with the matter. As it worked on ...

Chugai Pharmaceutical Co. is not in talks to become a wholly owned unit of Roche Holdings AG, contrary to a recent report about a $10 billion (¥1.02 trillion) share deal linked to the matter, the Tokyo-based drugmaker said. "Chugai is in no way in the ...